Scarica l'app Stockscreener
9.66
2.72%
-0.27
Dopo l'orario di chiusura:
9.72
0.06
+0.62%
Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie
Wedbush Predicts Weaker Earnings for Oric Pharmaceuticals - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Upgraded to Hold at Zacks Research - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Will ORIC Pharmaceuticals Inc. see short term momentumDividend Hike & Safe Capital Growth Tips - Newser
Oric Pharmaceuticals Faces Potential Setbacks Amid Competitors’ Clinical Trials - MSN
Chart Analysts Warn of Resistance Near ORIC Pharmaceuticals Inc. PriceJuly 2025 Levels & Community Verified Trade Signals - newsyoung.net
JPMorgan Chase & Co. Has Lowered Expectations for Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Given New $19.00 Price Target at HC Wainwright - MarketBeat
Market reaction to ORIC Pharmaceuticals Inc.’s recent newsJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
ORIC Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Decliners & Accurate Technical Buy Alerts - Newser
Will ORIC Pharmaceuticals Inc. continue its uptrend2025 Price Momentum & Community Driven Trade Alerts - Newser
Signal strength of ORIC Pharmaceuticals Inc. stock in tech scanners2025 Macro Impact & AI Driven Stock Movement Reports - Newser
Visual trend scoring systems applied to ORIC Pharmaceuticals Inc.July 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
How to manage a losing position in ORIC Pharmaceuticals Inc.July 2025 Drop Watch & Long Hold Capital Preservation Tips - Newser
Oric Pharmaceuticals' (ORIC) Buy Rating Reiterated at Guggenheim - MarketBeat
A Quick Look at Today's Ratings for Oric Pharmaceuticals(ORIC.US), With a Forecast Between $12 to $23 - 富途牛牛
How to forecast ORIC Pharmaceuticals Inc. trends using time series2025 Trade Ideas & AI Powered Market Entry Strategies - Newser
Jefferies Reiterates Buy Rating on Oric Pharmaceuticals with $23 Price Target. - AInvest
Guggenheim Reaffirms Buy Rating for ORIC Pharmaceuticals with $18 Target Price. - AInvest
Contineum Therapeutics shares fall 1.04% intraday after ORIC Pharmaceuticals reports positive clinical data and financing activity. - AInvest
Moving Average Trends for ORIC Pharmaceuticals Inc. Stock: What They IndicateWeekly Risk Report & Free Risk Controlled Daily Trade Plans - Newser
Guggenheim Reiterates Buy Rating for ORIC Pharmaceuticals | ORIC Stock News - GuruFocus
Guggenheim Keeps Buy Rating, Raises PT for ORIC Pharmaceuticals to $18. - AInvest
ORIC Pharmaceuticals stock price target raised to $23 by Jefferies - Investing.com Canada
Oric Pharmaceuticals Focuses on Lead Clinical Programs - MSN
ORIC Pharmaceuticals Inc. stock momentum explainedEarnings Miss & High Return Trade Opportunity Guides - Newser
Oppenheimer Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Can volume confirm reversal in ORIC Pharmaceuticals Inc.Portfolio Return Summary & Precise Buy Zone Tips - Newser
Using flow based indicators on ORIC Pharmaceuticals Inc.Real-Time Investment Signal Forecast with AI - Newser
Using economic indicators to assess ORIC Pharmaceuticals Inc. potentialStrategy Playbook for Risk Controlled Trades - Newser
ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates - GlobeNewswire
ORIC Pharmaceuticals Trims Costs To Back Key Drug Trials - Finimize
Vivo Capital LLC Buys 802,632 Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
Oric Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ORIC Pharmaceuticals reports Q2 net loss of $36.4 mln - MarketScreener
What makes ORIC Pharmaceuticals Inc. stock price move sharplySummary of Trade Cycles in 5-Year Range - Newser
Will a bounce in ORIC Pharmaceuticals Inc. offer an exitAI Trend Detection for Entry Timing - Newser
What data driven models say about ORIC Pharmaceuticals Inc.’s futureROI Prediction from Long-Term Holding Plans - Newser
What Fibonacci levels say about ORIC Pharmaceuticals Inc. reboundPrice Forecast Based on AI Analysis - Newser
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):